Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy D Warner

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Plos One|October 27, 2011
Endogenous epoxygenases are modulators of monocyte/macrophage activityJonas Bystrom, Jessica A Wray, Mary C Sugden, et al.
Plos One|October 14, 2009
The epoxygenases CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivoJessica A Wray, Mary C Sugden, Darryl C Zeldin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 25, 2013
Aspirin-triggered 15-epi-lipoxin A4 predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical testNicholas S Kirkby, Melissa V Chan, Martina H Lundberg, et al.
British Journal of Clinical Pharmacology|November 13, 2015
P2Y12 receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activationMelissa V Chan, Rebecca B M Knowles, Martina H Lundberg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 4, 2010
Role of shear stress in endothelial cell morphology and expression of cyclooxygenase isoformsClaire M F Potter, Martina H Lundberg, Louise S Harrington, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2012
Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular systemNicholas S Kirkby, Martina H Lundberg, Louise S Harrington, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 18, 2015
Inherited human group IVA cytosolic phospholipase A2 deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generationNicholas S Kirkby, Daniel M Reed, Matthew L Edin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 17, 2017
Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated PlateletsAmanda J Unsworth, Alexander P Bye, Dionne S Tannetta, et al.
Plos One|July 23, 2013
LC-MS/MS confirms that COX-1 drives vascular prostacyclin whilst gene expression pattern reveals non-vascular sites of COX-2 expressionNicholas S Kirkby, Anne K Zaiss, Paula Urquhart, et al.
Journal of Thrombosis and Haemostasis : JTH|August 14, 2021
Proteome and functional decline as platelets age in the circulationHarriet E Allan, Melissa A Hayman, Simone Marcone, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Plos One|October 27, 2011
Endogenous epoxygenases are modulators of monocyte/macrophage activityJonas Bystrom, Jessica A Wray, Mary C Sugden, et al.
Plos One|October 14, 2009
The epoxygenases CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivoJessica A Wray, Mary C Sugden, Darryl C Zeldin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 25, 2013
Aspirin-triggered 15-epi-lipoxin A4 predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical testNicholas S Kirkby, Melissa V Chan, Martina H Lundberg, et al.
British Journal of Clinical Pharmacology|November 13, 2015
P2Y12 receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activationMelissa V Chan, Rebecca B M Knowles, Martina H Lundberg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 4, 2010
Role of shear stress in endothelial cell morphology and expression of cyclooxygenase isoformsClaire M F Potter, Martina H Lundberg, Louise S Harrington, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2012
Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular systemNicholas S Kirkby, Martina H Lundberg, Louise S Harrington, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 18, 2015
Inherited human group IVA cytosolic phospholipase A2 deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generationNicholas S Kirkby, Daniel M Reed, Matthew L Edin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 17, 2017
Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated PlateletsAmanda J Unsworth, Alexander P Bye, Dionne S Tannetta, et al.
Plos One|July 23, 2013
LC-MS/MS confirms that COX-1 drives vascular prostacyclin whilst gene expression pattern reveals non-vascular sites of COX-2 expressionNicholas S Kirkby, Anne K Zaiss, Paula Urquhart, et al.
Journal of Thrombosis and Haemostasis : JTH|August 14, 2021
Proteome and functional decline as platelets age in the circulationHarriet E Allan, Melissa A Hayman, Simone Marcone, et al.
Pageof 12